Loading data
IMANasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 800 k USD | 3.5 m USD | 9.16 m USD | 15.62 m USD | 30.99 m USD |
| Research and development expense | 28.53 m USD | 32.11 m USD | 21.93 m USD | 64.32 m USD | 47.11 m USD |
| Operating profit | -48.45 m USD | -37 m USD | -21.93 m USD | -70.9 m USD | -34.14 m USD |
| Profit before tax | -45.7 m USD | -36.56 m USD | -20.87 m USD | -68.77 m USD | — |
| Income tax expense | -350 k USD | 13 k USD | 280 k USD | — | — |
| Net income (reported basis) | -45.35 m USD | -36.6 m USD | -21.15 m USD | -68.77 m USD | -34.12 m USD |
| Net income attributable to common shareholders | -52.4 m USD | -48.38 m USD | -32.04 m USD | — | — |
| Basic earnings per share | -9.64 USD/share | -22.1 USD/share | 16.23 USD/share | -1.9 USD/share | -1.22 USD/share |
| Diluted earnings per share | -9.64 USD/share | -22.1 USD/share | 16.23 USD/share | -1.9 USD/share | -1.22 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.